Navigation Links
Bionovo Reports First Quarter 2008 Financial Results
Date:5/9/2008

EMERYVILLE, Calif., May 9 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced results for the first quarter of 2008.

Quarter Results

The company did not report any revenue for the three months ended March 31, 2008. Revenues for the three months ended March 31, 2007 were $3,750, received from our licensing and technology transfer agreement with United Biotechnology Corporation of Taiwan. In October of 2007, we terminated the agreement following notice of material breach of the Agreement by UBC and we recognized the remaining deferred revenue of $91,250 in December 2007.

Total operating expenses for the three months ending March 31, 2008 were $4.2 million compared to $3.5 million for the same period in 2007.

The company reported a net loss for the three months ended March 31, 2008 of $3.9 million, or $0.05 per share, compared with a net loss of $3.3 million, or $0.05 per share, for the same period in 2007.

The Company ended the quarter with $29.4 million in cash, cash equivalents and short term investments, and began the quarter with $33.3 million, a difference of $3.9 million.

Company Highlights

-- Patient enrollment and dosing continues in the Phase 1 portion of the

BZL101 Phase 1/2 clinical trial for advanced metastatic breast cancer.

Presentations, papers and scientific discussions have expounded the

mechanisms of action and described the positive progress to date.

-- Bionovo presented data on two additional preclinical anti-cancer drug

candidates -- BN107 and BN108 -- at the American Association of Cancer

Research (AACR) conference in April. BN107 induces apoptosis through

the mitochondrial path
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
2. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
3. Louis Drapeau Joins Bionovos Board of Directors
4. George Butler Joins Bionovos Board of Directors
5. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
6. Bionovo Announces Third Quarter 2007 Financial Results
7. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
8. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
9. Bionovo Announces Proposed Public Offering of Common Stock
10. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
11. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Controlled Substance Compliance ... which helps companies check the legal requirements around using ... to China. , As their international operations expand ... adopting software solutions built as a result of the ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2
... Imaging Diagnostic Systems, Inc., (OTC Bulletin ... will exhibit the CT Laser Mammography (CTLM(R)) system at the ... United Arab Emirates (UAE). The company will demonstrate the ... the UAE and intends to secure prospective sales of the ...
... Jan. 27 As farmers,look to get more out ... MON ) is exploring unique ways to discover ... collaboration with GrassRoots,Biotechnology Inc. is expected to do just ... portfolio for its farmer customer. , ...
... Jan. 27 InNexus Biotechnology Inc. (OTC Bulletin Board: ... that it has completed a second private placement on ... that was completed 12 December 2008.The private placement, totaled ... will be convertible into common shares of InNexus at ...
Cached Biology Technology:Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4InNexus Completes Previously Announced Private Placement 2
(Date:1/22/2015)... MUNICH , January 22, 2015 ... its tenth year  The European Patent Office to present ... Two British nominations to be featured: Christofer Toumazou ... week featuring former finalists and winners of the Award   ...
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch in December ... people to eliminate the pain of trying to remember their ... own biometrics fused to their smartphones. To assist people who ... , the company that created 1U and focuses on redefining ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... San Diego have discovered that an important class of stem ... from an individual,s own cells, could face immune rejection problems ... In today,s advance online issue of the journal Nature ... system rejection of cells derived from autologous iPSCs that can ...
... is Not Boring!" asserts the introduction to a recent ... December 2010). On the contrary, the ways in which ... building blocks of macromolecules are crucial for life. And ... single-celled to multicellular organisms. This gives special importance to ...
... a slide that has a photo of a cornfield and ... studies photosynthesis at Washington University in St. Louis. "When I ... more efficient. Invariably the audience votes overwhelmingly in favor of ... its surprising answer (below) is the point of departure for ...
Cached Biology News:Study finds therapies using induced pluripotent stem cells could encounter immune rejection problems 2Turning plants into power houses 2Turning plants into power houses 3Turning plants into power houses 4Turning plants into power houses 5Turning plants into power houses 6
...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
Biology Products: